9.80
+0.26(+2.73%)
Currency In USD
Address
3525 Del Mar Heights Road
San Diego, CA 92130
United States of America
Phone
858 335 1300
Website
Sector
Healthcare
Industry
Biotechnology
Employees
155
First IPO Date
December 04, 2020
| Name | Title | Pay | Year Born |
| Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL | Co-Founder, President, Chief Executive Officer & Director | 3.33M | 1966 |
| Mr. Eric Karas | Chief Commercial Officer | 618,614 | 1973 |
| Mr. Alexander A. Fitzpatrick Esq. | Chief Legal Officer & Secretary | 677,145 | 1967 |
| Mr. Brian T. Dorsey M.S. | Chief Operating Officer | 706,970 | 1969 |
| Dr. Sarina Tanimoto M.B.A., M.D. | Co-Founder & Chief Medical Officer | 2.94M | 1969 |
| Ms. Kathleen D. Scott CPA | Chief Financial Officer | 0 | N/A |
| Dr. Robert Bell Ph.D. | Co-Founder & Chief Science Officer | 0 | N/A |
| Mr. Harris Kaplan M.B.A. | Executive Vice President of Commercial Strategy | 0 | 1952 |
| Mr. Daniel Relovsky | Senior Vice President of Marketing | 0 | N/A |
| Mr. Justin Chakma | Chief Business Officer | 0 | 1990 |
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.